ShareValue scores for 002099.SHE: Valuation 53, Quality 32, Growth 39, Health 49.

002099.SHE
SZSE

Zhejiang Hisoar Pharmaceutical Co Ltd

CN¥5.36(+1.71%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
53
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
23
Bearish
Price Trend

Company Details

About

Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies and appliances; and other chemical intermediates. In addition, the company engages in technology research and development; trading; hazardous waste treatment; equity investment; technical consulting and other consulting services; and venture capital activities. It exports its products to approximately 30 countries, including Europe, America, and Asia. Zhejiang Hisoar Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taizhou, China. Address: No. 100, Waisha Branch Road, Taizhou, China, 318000

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026